Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Topical Timolol 0.5% in Wound Healing and Scar Improvement Following Atrophic Acne Scar Microneedling

NCT05597813 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05597813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Topical Timolol 0.5% in Wound Healing and Scar Improvement Following Atrophic Acne Scar Microneedling
Lead sponsor
Zagazig University
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2023
Completion date
November 1, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acne scars - mixed atrophic and hypertrophic